Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomized, double-blind study of the effect of treatment duration and dose of PEGASYS on HBeAg seroconversion and safety in patients with HBeAg positive chronic hepatitis B.
peg-interferon alpha-2a
WV19432
NCT00435825
chronic hepatitis b
Phase 4
 
January 2014

Powered by ideaPoint, Inc.